Journal of Applied Physiology Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 103: 1263-1268, 2007. First published August 2, 2007; doi:10.1152/japplphysiol.01287.2006
8750-7587/07 $8.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
103/4/1263    most recent
01287.2006v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamauchi, M.
Right arrow Articles by Strohl, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamauchi, M.
Right arrow Articles by Strohl, K. P.

Acetazolamide protects against posthypoxic unstable breathing in the C57BL/6J mouse

Motoo Yamauchi,1,2 Jesse Dostal,2 and Kingman P. Strohl1,2

1Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Case Western Reserve University, and 2Louis Stokes Department of Veterans Affairs Medical Center, Cleveland, Ohio

Submitted 14 November 2006 ; accepted in final form 30 July 2007

Acetazolamide (Acz), a carbonic anhydrase inhibitor, is used to manage periodic breathing associated with altitude and with heart failure. We examined whether Acz would alter posthypoxic ventilatory behavior in the C57BL/6J (B6) mouse model of recurrent central apnea. Experiments were performed with unanesthetized, awake adult male B6 mice (n = 9), ventilatory behavior was measured using flow-through whole body plethysmography. Mice were given an intraperitoneal injection of either vehicle or Acz (40 mg/kg), and 1 h later they were exposed to 1 min of 8% O2-balance N2 (poikilocapnic hypoxia) or 12% O2-3% CO2-balance N2 (isocapnic hypoxia) followed by rapid reoxygenation (100% O2). Hypercapnic response (8% CO2-balance O2) was examined in six mice. With Acz, ventilation, including respiratory frequency, tidal volume, and minute ventilation, in room air was significantly higher and hyperoxic hypercapnic ventilatory responsiveness was generally lower compared with vehicle. Poikilocapnic and isocapnic hypoxic ventilatory responsiveness were similar among treatments. One minute after reoxygenation, animals given Acz exhibited posthypoxic frequency decline, a lower coefficient of variability for frequency, and no tendency toward periodic breathing, compared with vehicle treatment. We conclude that Acz improves unstable breathing in the B6 model, without altering hypoxic response or producing short-term potentiation, but with some blunting of hypercapnic responsiveness.

ventilation; periodic breathing; carbonic anhydrase inhibitor



Address for reprint requests and other correspondence: M. Yamauchi: VA Medical Center, Research Service K216, 10701 East Blvd., Cleveland, OH 44106 (e-mail: mountain{at}pastel.ocn.ne.jp)




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
J. M. Bissonnette and S. J. Knopp
Effect of inspired oxygen on periodic breathing in methy-CpG-binding protein 2 (Mecp2) deficient mice
J Appl Physiol, January 1, 2008; 104(1): 198 - 204.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.